A homozygous CAP2 pathogenic variant in a neonate presenting with rapidly progressive cardiomyopathy and nemaline rods.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
03 2022
Historique:
revised: 21 10 2021
received: 17 06 2021
accepted: 02 11 2021
pubmed: 5 12 2021
medline: 19 4 2022
entrez: 4 12 2021
Statut: ppublish

Résumé

Nemaline Myopathy (NM) is a disorder of skeletal muscles caused by mutations in sarcomere proteins and characterized by accumulation of microscopic rod or thread-like structures (nemaline bodies) in skeletal muscles. Patients diagnosed with both NM and infantile cardiomyopathy are very rare. A male infant presented, within the first few hours of life, with severe dilated cardiomyopathy, biventricular dysfunction and left ventricular noncompaction. A muscle biopsy on the 8th day of life from the right sternocleidomastoid muscle identified nemaline rods. Whole exome sequencing identified a c.1288 delT (homozygous pathogenic variant) in the CAP2 gene (NM_006366), yielding a CAP2 protein (NP_006357.1) with a p.C430fs. Both parents were heterozygous for the same variant but have no history of heart or muscle disease. Analysis of patient derived fibroblasts and cardiomyocytes derived from induced pluripotent stem cells confirmed the p.C430fs mutation (pathogenic variant), which appears to cause loss of both CAP2 protein and mRNA. The CAP2 gene encodes cyclase associated protein 2, an actin monomer binding and filament depolymerizing protein and CAP2 knockout mice develop severe dilated cardiomyopathy and muscle weakness. The patient underwent a heart transplant at 1 year of age. Heart tissue explanted at that time also showed nemaline rods and additionally disintegration of the myofibrillar structure. Other extra cardiac concerns include mild hypotonia, atrophic and widened scarring. This is the first description of a patient presenting with nemaline myopathy associated with a pathogenic variant of CAP2.

Identifiants

pubmed: 34862840
doi: 10.1002/ajmg.a.62590
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
CAP2 protein, human 0
Membrane Proteins 0

Types de publication

Case Reports Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

970-977

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL134923
Pays : United States

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Agrawal, P. B., Joshi, M., Savic, T., Chen, Z., & Beggs, A. H. (2012). Normal myofibrillar development followed by progressive sarcomeric disruption with actin accumulations in a mouse Cfl2 knockout demonstrates requirement of cofilin-2 for muscle maintenance. Human Molecular Genetics, 21(10), 2341-2356. https://doi.org/10.1093/hmg/dds053
Aspit, L., Levitas, A., Etzion, S., Krymko, H., Slanovic, L., Zarivach, R., Etzion, Y., & Parvari, R. (2018). CAP2 Mutation leads to impaired Actin dynamics and associates with supraventricular tachycardia and dilated cardiomyopathy. Journal of Medical Genetics, 56, 228-235. https://doi.org/10.1136/jmedgenet-2018-105498
Celestino-Soper, P. B., Skinner, C., Schroer, R., Eng, P., Shenai, J., Nowaczyk, M. M., Cushing, D., Patel, G. S., Immken, L., Willis, A., Wiszniewska, J., Matalon, R., Rosenfeld, J. A., Stevenson, R. E., Kang, S.-H. L., Cheung, S. W., Beaudet, A. L., & Stankiewicz, P. (2012). Deletions in chromosome 6p22.3-p24.3, including ATXN1, are associated with developmental delay and autism spectrum disorders. Molecular Cytogenetics, 5, 17. https://doi.org/10.1186/1755-8166-5-17
Cheema, H., Bertoli-Avella, A. M., Skrahina, V., Anjum, M. N., Waheed, N., Saeed, A., Beetz, C., Perez-Lopez, J., Rocha, M. E., Alawbathani, S., Pereira, C., Hovakimyan, M., Patric, I. R. P., Paknia, O., Ameziane, N., Cozma, C., Bauer, P., & Rolfs, A. (2020). Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility. NPJ Genomic Medicine, 5, 44. https://doi.org/10.1038/s41525-020-00150-z
Colpan, M., Iwanski, J., & Gregorio, C. C. (2021). CAP2 is a regulator of actin pointed end dynamics and myofibrillogenesis in cardiac muscle. Communications Biology, 4(1), 365. https://doi.org/10.1038/s42003-021-01893-w
Conen, P. E., Murphy, E. G., & Donohue, W. L. (1963). Light and electron microscopic studies of "Myogranules" in a child with hypotonia and muscle weakness. Canadian Medical Association Journal, 89, 983-986.
de Winter, J. M., & Ottenheijm, C. A. C. (2017). Sarcomere dysfunction in nemaline myopathy. Journal of Neuromuscular Diseases, 4(2), 99-113. https://doi.org/10.3233/JND-160200
Dipchand, A. I., Kirk, R., Edwards, L. B., Kucheryavaya, A. Y., Benden, C., Christie, J. D., Dobbels, F., Lund, L. H., Rahmel, A. O., Yusen, R. D., Stehlik, J., & International Society for Heart and Lung Transplantation. (2013). The registry of the International Society for Heart and Lung Transplantation: Sixteenth official pediatric heart transplantation report-2013; focus theme: Age. The Journal of Heart and Lung Transplantation, 32(10), 979-988. https://doi.org/10.1016/j.healun.2013.08.005
Fedor-Chaiken, M., Deschenes, R. J., & Broach, J. R. (1990). SRV2, a gene required for RAS activation of adenylate cyclase in yeast. Cell, 61, 329-340. https://doi.org/10.1016/0092-8674(90)90813-T
Feingold, B., Mahle, W. T., Auerbach, S., Clemens, P., Domenighetti, A. A., Jefferies, J. L., Judge, D. P., Lal, A. K., Markham, L. W., Parks, W. J., Tsuda, T., Wang, P. J., Yoo, S.-J., On behalf of the American Heart Association Pediatric Heart Failure Committee of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Radiology and Intervention, Council on Functional Genomics and Translational Biology, & Stroke Council. (2017). Management of cardiac involvement associated with neuromuscular diseases: A scientific statement from the American Heart Association. Circulation, 136(13), e200-e231. https://doi.org/10.1161/CIR.0000000000000526
Field, J., Nikawa, J., Broek, D., MacDonald, B., Rodgers, L., Wilson, I. A., Lerner, R. A., & Wigler, M. (1988). Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method. Molecular and Cellular Biology, 8, 2159-2165. https://doi.org/10.1128/MCB.8.5.2159
Field, J., Vojtek, A., Ballester, R., Bolger, G., Colicelli, J., Ferguson, K., Gerst, J. E., Kataoka, T., Michaeli, T., & Powers, S. (1990). Cloning and characterization of CAP, the S. cerevisiae gene encoding the 70 kd adenylyl cyclase-associated protein. Cell, 61(2), 319-327. https://doi.org/10.1016/0092-8674(90)90812-S
Field, J., Ye, D. Z., Shinde, M., Liu, F., Schillinger, K. J., Lu, M., Wang, T., Skettini, M., Xiong, Y., Brice, A. K., Chung, D. C., & Patel, V. V. (2015). CAP2 in cardiac conduction, sudden cardiac death and eye development. Scientific Reports, 5, 17256. https://doi.org/10.1038/srep17256
Finsterer, J., & Stöllberger, C. (2015). Review of cardiac disease in Nemaline myopathy. Pediatric Neurology, 53(6), 473-477. https://doi.org/10.1016/j.pediatrneurol.2015.08.014
Gatayama, R., Ueno, K., Nakamura, H., Yanagi, S., Ueda, H., Yamagishi, H., & Yasui, S. (2013). Nemaline myopathy with dilated cardiomyopathy in childhood. Pediatrics, 131(6), e1986-e1990. https://doi.org/10.1542/peds.2012-1139
Gerst, J. E., Ferguson, K., Vojtek, A., Wigler, M., & Field, J. (1991). CAP is a bifunctional component of the Saccharomyces cerevisiae adenylyl cyclase complex. Molecular and Cellular Biology, 11(3), 1248-1257.
Holbrook, J. A., Neu-Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004). Nonsense-mediated decay approaches the clinic. Nature Genetics, 36(8), 801-808. https://doi.org/10.1038/ng1403
Karpati, G., Carpenter, S., & Andermann, F. (1971). A new concept of childhood nemaline myopathy. Archives of Neurology, 24(4), 291-304. https://doi.org/10.1001/archneur.1971.00480340023002
Kepser, L. J., Damar, F., De Cicco, T., Chaponnier, C., Proszynski, T. J., Pagenstecher, A., & Rust, M. B. (2019). CAP2 deficiency delays myofibril Actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function. Proceedings of the National Academy of Sciences of the United States of America, 116, 8397-8402. https://doi.org/10.1073/pnas.1813351116
Kirk, R., Naftel, D., Hoffman, T. M., Almond, C., Boyle, G., Caldwell, R. L., Kirklin, J. K., White, K., Dipchand, A. I., & Pediatric Heart Transplant Study Investigators. (2009). Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: A multi-institutional study. The Journal of Heart and Lung Transplantation, 28(12), 1322-1328. https://doi.org/10.1016/j.healun.2009.05.027
Kosmas, K., Eskandarnaz, A., Khorsandi, A. B., Kumar, A., Ranjan, R., Eming, S. A., Noegel, A. A., & Peche, V. S. (2015). CAP2 is a regulator of the actin cytoskeleton and its absence changes infiltration of inflammatory cells and contraction of wounds. European Journal of Cell Biology, 94(1), 32-45. https://doi.org/10.1016/j.ejcb.2014.10.004
Kotila, T., Kogan, K., Enkavi, G., Guo, S., Vattulainen, I., Goode, B. L., & Lappalainen, P. (2018). Structural basis of actin monomer re-charging by cyclase-associated protein. Nature Communications, 9(1), 1892. https://doi.org/10.1038/s41467-018-04231-7
Kumar, A., Paeger, L., Kosmas, K., Kloppenburg, P., Noegel, A. A., & Peche, V. S. (2016). Neuronal ctin dynamics, spine density and neuronal dendritic complexity are regulated by CAP2. Frontiers in Cellular Neuroscience, 10, 180. https://doi.org/10.3389/fncel.2016.00180
Lipshultz, S. E., Law, Y. M., Asante-Korang, A., Austin, E. D., Dipchand, A. I., Everitt, M. D., Hsu, D. T., Lin, K. Y., Price, J. F., Wilkinson, J. D., & Colan, S. D. (2019). Cardiomyopathy in children: Classification and diagnosis: A scientific statement from the American Heart Association. Circulation, 140(1), CIR0000000000000682. https://doi.org/10.1161/CIR.0000000000000682
Malfatti, E., Bohm, J., Lacene, E., Beuvin, M., Romero, N. B., & Laporte, J. (2015). A premature stop codon in MYO18B is associated with severe nemaline myopathy with cardiomyopathy. Journal of Neuromuscular Diseases, 2(3), 219-227. https://doi.org/10.3233/JND-150085
Mintzer, K. A., & Field, J. (1994). Interactions between adenylyl cyclase, CAP and RAS from Saccharomyces cerevisiae. Cellular Signalling, 6, 681-694. https://doi.org/10.1016/0898-6568(94)90050-7
Ono, S. (2013). The role of cyclase-associated protein in regulating Actin filament dynamics - More than a monomer-sequestration factor. Journal of Cell Science, 126(15), 3249-3258. https://doi.org/10.1242/jcs.128231
Patel, R., & Peterson, R. (2019). Cardiomyopathy presenting prenatally with functional tricuspid and pulmonary atresia. Echocardiography, 36, 1779-1782. https://doi.org/10.1111/echo.14446
Peche, V., Holak, T., Burgute, B., Kosmas, K., Kale, S., Wunderlich, F., Elhamine, F., Stehle, R., Pfitzer, G., Nohroudi, K., Addicks, K., Stöckigt, F., Schrickel, J. W., Gallinger, J., Schleicher, M., & Noegel, A. (2013). Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cellular and Molecular Life Sciences, 70, 527-543. https://doi.org/10.1007/s00018-012-1142-y
Schneider, F., Duong, T. A., Metz, I., Winkelmeier, J., Hubner, C. A., Endesfelder, U., & Rust, M. B. (2021). Mutual functional dependence of cyclase-associated protein 1 (CAP1) and cofilin1 in neuronal actin dynamics and growth cone function. Progress in Neurobiology, 202, 102050. https://doi.org/10.1016/j.pneurobio.2021.102050
Schranz, D., Rupp, S., Muller, M., Schmidt, D., Bauer, A., Valeske, K., Michel-Behnke, I., Jux, C., Apitz, C., Thul, J., Hsu, D., & Akinturk, H. (2013). Pulmonary artery banding in infants and young children with left ventricular dilated cardiomyopathy: A novel therapeutic strategy before heart transplantation. The Journal of Heart and Lung Transplantation, 32(5), 475-481. https://doi.org/10.1016/j.healun.2013.01.988
Sewry, C. A., Laitila, J. M., & Wallgren-Pettersson, C. (2019). Nemaline myopathies: A current view. Journal of Muscle Research and Cell Motility, 40(2), 111-126. https://doi.org/10.1007/s10974-019-09519-9
Shy, G. M., Engel, W. K., Somers, J. E., & Wanko, T. (1963). Nemaline myopathy. A new congenital myopathy. Brain, 86, 793-810. https://doi.org/10.1093/brain/86.4.793
Stockigt, F., Peche, V. S., Linhart, M., Nickenig, G., Noegel, A. A., & Schrickel, J. W. (2016). Deficiency of cyclase-associated protein 2 promotes arrhythmias associated with connexin43 maldistribution and fibrosis. Archives of Medical Science, 12(1), 188-198. https://doi.org/10.5114/aoms.2015.54146
Taliun, D., Harris, D. N., Kessler, M. D., Carlson, J., Szpiech, Z. A., Torres, R., Gagliano Taliun, S. A., Corvelo, A., Gogarten, S. M., Kang, H. M., Pitsillides, A. N., LeFaive, J., Lee, S.-b., Tian, X., Browning, B. L., Das, S., Emde, A.-K., Clarke, W. E., Loesch, D. P., … Qasba, P. (2021). Sequencing of 53,831 diverse genomes from the NHLBI TOPMed program. Nature, 590(7845), 290-299. https://doi.org/10.1038/s41586-021-03205-y
Towbin, J. A. (2010). Left ventricular noncompaction: A new form of heart failure. Heart Failure Clinics, 6(4), 453-469, viii. https://doi.org/10.1016/j.hfc.2010.06.005
Towbin, J. A., Lowe, A. M., Colan, S. D., Sleeper, L. A., Orav, E. J., Clunie, S., Messere, J., Cox, G. F., Lurie, P. R., Hsu, D., Canter, C., Wilkinson, J. D., & Lipshultz, S. E. (2006). Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA, 296(15), 1867-1876. https://doi.org/10.1001/jama.296.15.1867
Xiong, Y., Bedi, K. C., Berritt, S., Brooks, T. G., Attipoe, B. K., Wang, K., Margulies, K. B., & Field, J. (2019). Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset. JCI Insight, 4(6). https://doi.org/10.1172/jci.insight.124629
Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., Braxton, A., Beuten, J., Xia, F., Niu, Z., Hardison, M., Person, R., Bekheirnia, M. R., Leduc, M. S., Kirby, A., Pham, P., Scull, J., Wang, M., Ding, Y., … Eng, C. M. (2013). Clinical whole-exome sequencing for the diagnosis of mendelian disorders. The New England Journal of Medicine, 369(16), 1502-1511. https://doi.org/10.1056/NEJMoa1306555
Zhang, X., Pizzoni, A., Hong, K., Naim, N., Qi, C., Korkhov, V., & Altschuler, D. L. (2021). CAP1 binds and activates adenylyl cyclase in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America, 118(24), e2024576118. https://doi.org/10.1073/pnas.2024576118

Auteurs

Sharavana Gurunathan (S)

Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Jessica Sebastian (J)

Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Jennifer Baker (J)

Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Hoda Z Abdel-Hamid (HZ)

Department of Pediatrics, Division of Child Neurology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Shawn C West (SC)

Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Brian Feingold (B)

Department of Pediatrics and Clinical and Translational Science, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Vivek Peche (V)

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

Miguel Reyes-Múgica (M)

Department of Pathology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Suneeta Madan-Khetarpal (S)

Department of Pediatrics, Division of Medical Genetics and Genomic Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Jeffrey Field (J)

Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH